Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-172 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A90-10 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B20-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B20-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12M1-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12M1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-44 |
filingDate |
2008-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2010-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2010527603-A |
titleOfInvention |
Genetic variation on CHR5p12 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment |
abstract |
The present invention relates to certain genetic variants on Chr5p12 and Chr10q26 as susceptible variants of breast cancer. Methods for disease management, including diagnosis of increased and / or decreased susceptibility to breast cancer, methods for predicting response to therapy, and methods for predicting prognosis using such variants are described. The present invention further relates to kits useful in the methods of the present invention. [Selection figure] None |
priorityDate |
2007-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |